Molina Healthcare, Inc.

NYSE:MOH

330.66 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999
Revenue 34,07231,97427,77119,42316,82918,89019,88317,71114,0729,666.6016,588.9346,028.7634,769.944,085.9773,669.3563,112.3662,492.4542,004.9951,650.0581,175.268793.544644.194503.855329.432185.76
Cost of Revenue 29,73828,04824,49116,74614,39416,26618,00315,94112,4348,616.0745,713.6355,396.9594,003.9813,449.5043,176.2362,621.3122,080.0831,678.6521,424.872984.686657.9210408.4100
Gross Profit 4,3343,9263,2802,6772,4352,6241,8801,7701,6381,050.527875.299631.804765.959636.473493.12491.054412.371326.343225.186190.582135.623644.19495.445329.432185.76
Gross Profit Ratio 0.1270.1230.1180.1380.1450.1390.0950.10.1160.1090.1330.1050.1610.1560.1340.1580.1650.1630.1360.1620.17110.18911
Reseach & Development Expenses 0000000000000000000000000
General & Administrative Expenses 2,4622,3112,0681,4801,2961,3331,5941,3931,147764.693665.996532.627415.932345.993399.149344.761285.295229.057163.34294.1561.54361.227000
Selling & Marketing Expenses 115000000000000000000000000
SG&A 2,4622,3112,0681,4801,2961,3331,5941,3931,147764.693665.996532.627415.932345.993399.149344.761285.295229.057163.34294.1561.54361.22742.82238.70118.511
Other Expenses -3,83023419211989-17611392-0.802-3.3430.361205.279185.47938.1133.68828.74921.47516.0648.8696.333045.22900
Operating Expenses 2,7612,5452,2601,5991,3851,4321,7311,5321,251857.61738.739596.331621.211531.472437.259378.449314.044250.532179.406103.01967.876-534.1345.229305.194168.274
Operating Income 1,5731,1731,0201,0781,0441,131-555238387192.917136.5635.47380.173105.00157.393112.60598.32775.81145.7887.56367.7471,178.32450.21624.23817.486
Operating Income Ratio 0.0460.0370.0370.0560.0620.06-0.0280.0130.0280.020.0210.0060.0170.0260.0160.0360.0390.0380.0280.0750.0851.8290.10.0740.094
Total Other Income Expenses Net -109-110-145-117-72-78-643382-0.802-3.3430.361-64.575-15.5091.53221.126-4.631-2.353-0.41.1710.118-1,129.925-0.561-0.197-1.19
Income Before Tax 1,4641,063875961972999-612137322135.30481.14619.06564.65489.49243.616103.89193.69673.45843.85187.68566.41348.39949.65524.04116.296
Income Before Tax Ratio 0.0430.0330.0320.0490.0580.053-0.0310.0080.0230.0140.0120.0030.0140.0220.0120.0330.0380.0370.0270.0750.0840.0750.0990.0730.088
Income Tax Expense 373271216288235292-10012917972.72636.3169.27543.83634.52212.74841.49335.36627.73116.25531.91223.89617.89119.4539.0778.033
Net Income 1,091792659673737707-512814362.22352.9299.7920.81854.9730.86862.39858.3345.72727.59655.77342.51730.50830.12914.9649.453
Net Income Ratio 0.0320.0250.0240.0350.0440.037-0.02600.010.0060.0080.0020.0040.0130.0080.020.0230.0230.0170.0470.0540.0470.060.0450.051
EPS 18.9113.711.411.4111.8510.61-9.140.932.751.331.160.210.451.340.791.51.371.090.671.381.271.021.010.50.31
EPS Diluted 18.7813.5411.2511.2411.4810.55-9.140.922.581.291.130.210.451.320.791.51.371.080.651.361.250.990.970.490.31
EBITDA 1,7441,5571,1261,1511,1541,302388420515326.519227.083114.598219.131165.76693.971147.919126.29497.28661.30595.26173.9621,182.43652.62326.32320.301
EBITDA Ratio 0.0510.0490.0410.0590.0690.0690.020.0240.0370.0340.0340.0190.0460.0410.0260.0480.0510.0490.0370.0810.0931.8360.1040.080.109